Granzyme B: pro-apoptotic, antiviral and antitumor functions

被引:206
作者
Trapani, JA [1 ]
Sutton, VR [1 ]
机构
[1] Peter MacCallum Canc Ctr, Div Res, Canc Immunol Program, Melbourne, Vic 8006, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0952-7915(03)00107-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Granzyme B is a caspase-like serine protease that is released by cytotoxic lymphocytes to kill virus-infected and tumor cells. Major recent advances in our understanding of granzyme B biochemistry, biology and function include an appreciation of its uptake into and trafficking within target cells, a thorough dissection of how cell death is triggered, and the identification of the serpin protease inhibitor PI-9, which regulates its function in lymphocytes and in other cells. The roles that granzyme B plays in human pathologies, such as transplant rejection, viral immunity and particularly tumor immune surveillance, remain a topic for vigorous debate and conjecture. The recent discovery of a triply mutated human granzyme B allele, whose product is predicted to possess a reduced capacity to induce cell death, opens the way for major progress in these areas in coming years.
引用
收藏
页码:533 / 543
页数:11
相关论文
共 92 条
  • [1] Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition
    Alimonti, JB
    Shi, LF
    Baijal, PK
    Greenberg, AH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 6974 - 6982
  • [2] Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis
    Andrade, F
    Roy, S
    Nicholson, D
    Thornberry, N
    Rosen, A
    Casciola-Rosen, L
    [J]. IMMUNITY, 1998, 8 (04) : 451 - 460
  • [3] Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death
    Andrade, F
    Bull, HG
    Thornberry, NA
    Ketner, GW
    Casciola-Rosen, LA
    Rosen, A
    [J]. IMMUNITY, 2001, 14 (06) : 751 - 761
  • [4] Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection
    Balkow, S
    Kersten, A
    Tran, TTT
    Stehle, T
    Grosse, P
    Museteanu, C
    Utermöhlen, O
    Pircher, H
    von Weizsäcker, F
    Wallich, R
    Müllbacher, A
    Simon, MM
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (18) : 8781 - 8791
  • [5] Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving bid
    Barry, M
    Heibein, JA
    Pinkoski, MJ
    Lee, SF
    Moyer, RW
    Green, DR
    Bleackley, RC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) : 3781 - 3794
  • [6] Cytotoxic T lymphocytes: All roads lead to death
    Barry, M
    Bleackley, RC
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) : 401 - 409
  • [7] Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway
    Bird, CH
    Sutton, VR
    Sun, JR
    Hirst, CE
    Novak, A
    Kumar, S
    Trapani, JA
    Bird, PI
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) : 6387 - 6398
  • [8] Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
    Bladergroen, BA
    Meijer, CJLM
    ten Berge, RL
    Hack, CE
    Muris, JJF
    Dukers, DF
    Chott, A
    Kazama, Y
    Oudejans, JJ
    van Berkum, O
    Kummer, JA
    [J]. BLOOD, 2002, 99 (01) : 232 - 237
  • [9] The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites
    Bladergroen, BA
    Strik, MCM
    Bovenschen, N
    van Berkum, O
    Scheffer, GL
    Meijer, CJLM
    Hack, CE
    Kummer, JA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 3218 - 3225
  • [10] The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor
    Blanchard, F
    Raher, S
    Duplomb, L
    Vusio, P
    Pitard, V
    Taupin, JL
    Moreau, JF
    Hoflack, B
    Minvielle, S
    Jacques, Y
    Godard, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) : 20886 - 20893